Remond Ja Fijneman
Overview
Explore the profile of Remond Ja Fijneman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
272
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vant Erve I, Rovers K, Constantinides A, Bolhuis K, Wassenaar E, Lurvink R, et al.
J Pathol Clin Res
. 2021 Feb;
7(3):203-208.
PMID: 33635598
Tumor-derived cell-free DNA (cfDNA) is an emerging biomarker for guiding the personalized treatment of patients with metastatic colorectal cancer (CRC). While patients with CRC liver metastases (CRC-LM) have relatively high...
2.
Komor M, Bosch L, Coupe V, Rausch C, Pham T, Piersma S, et al.
J Pathol
. 2019 Dec;
250(3):288-298.
PMID: 31784980
Screening to detect colorectal cancer (CRC) in an early or premalignant state is an effective method to reduce CRC mortality rates. Current stool-based screening tests, e.g. fecal immunochemical test (FIT),...
3.
Rovers K, Lurvink R, Wassenaar E, Kootstra T, Scholten H, Tajzai R, et al.
BMJ Open
. 2019 Jul;
9(7):e030408.
PMID: 31352425
Introduction: Repetitive electrostatic pressurised intraperitoneal aerosol chemotherapy with oxaliplatin (ePIPAC-OX) is offered as a palliative treatment option for patients with isolated unresectable colorectal peritoneal metastases (PM) in several centres worldwide....
4.
Marcuello M, Vymetalkova V, Neves R, Duran-Sanchon S, Vedeld H, Tham E, et al.
Mol Aspects Med
. 2019 Jun;
69:107-122.
PMID: 31189073
New non-invasive approaches that can complement and improve on current strategies for colorectal cancer (CRC) screening and management are urgently needed. A growing number of publications have documented that components...
5.
Komor M, Bosch L, Bounova G, Bolijn A, Delis-van Diemen P, Rausch C, et al.
J Pathol
. 2018 Jul;
246(3):266-276.
PMID: 29968252
Consensus molecular subtyping is an RNA expression-based classification system for colorectal cancer (CRC). Genomic alterations accumulate during CRC pathogenesis, including the premalignant adenoma stage, leading to changes in RNA expression....
6.
Sillars-Hardebol A, Carvalho B, Belien J, de Wit M, Delis-van Diemen P, Tijssen M, et al.
J Pathol
. 2011 Oct;
226(3):442-50.
PMID: 22009326
Colorectal cancer (CRC) is the second leading cause of cancer death in the western world. The majority of CRCs, which develop from adenoma precursor lesions, show gain of chromosome arm...